AGILE (Early Phase Platform Trial for COVID-19) Read more about AGILE (Early Phase Platform Trial for COVID-19)
Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19) Read more about Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19)
Analysis of the Pathophysiology and Pathology of Coronavirus Disease 2019 (COVID-19), Including Chronic Morbidity Read more about Analysis of the Pathophysiology and Pathology of Coronavirus Disease 2019 (COVID-19), Including Chronic Morbidity
Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19) Read more about Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19)
SARS-CoV-2 (COVID-19) Longitudinal Study: Understanding Susceptibility, Transmission and Disease Severity (Legacy Study) Read more about SARS-CoV-2 (COVID-19) Longitudinal Study: Understanding Susceptibility, Transmission and Disease Severity (Legacy Study)
Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) Read more about Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)
Comparison of Cardiopulmonary Fitness Level With Normal Values After COVID-19 Read more about Comparison of Cardiopulmonary Fitness Level With Normal Values After COVID-19
Expanded Access Program for Autologous Muscle Derived Cells (AMDCs) Read more about Expanded Access Program for Autologous Muscle Derived Cells (AMDCs)
AffyImmune Therapeutics, Inc. By efain on Thu, 02/11/2021 - 17:19 Read more about AffyImmune Therapeutics, Inc.